Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (94)

2024

  1. Editorial: Pathophysiology of bone and mineral metabolism

    Frontiers in Physiology

  2. Novel Biomarkers of Bone Metabolism

    Nutrients, Vol. 16, Núm. 5

  3. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Dietary phosphate restriction prevents the appearance of sarcopenia signs in old mice

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 14, Núm. 2, pp. 1060-1074

  2. Effects of a Losartan-Antioxidant Hybrid (GGN1231) on Vascular and Cardiac Health in an Experimental Model of Chronic Renal Failure

    Nutrients, Vol. 15, Núm. 8

  3. Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  4. MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 7, pp. 1729-1740

  5. Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2589-2597

  6. Phosphorus May Induce Phenotypic Transdifferentiation of Vascular Smooth Muscle Cells through the Reduction of microRNA-145

    Nutrients, Vol. 15, Núm. 13

  7. Redox Metabolism and Vascular Calcification in Chronic Kidney Disease

    Biomolecules, Vol. 13, Núm. 9

  8. Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes

    International journal of molecular sciences, Vol. 24, Núm. 6

  9. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment

    Nutrients, Vol. 15, Núm. 6

2022

  1. A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D-a randomised multicentre international clinical trial

    BMC medicine, Vol. 20, Núm. 1, pp. 83

  2. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

  3. Spanish National Registry of Major Osteoporotic Fractures (REFRA) seen at Fracture Liaison Services (FLS): objectives and quality standards

    Archives of Osteoporosis, Vol. 17, Núm. 1

  4. Vitamin D Treatment Prevents Uremia-Induced Reductions in Aortic microRNA-145 Attenuating Osteogenic Differentiation despite Hyperphosphatemia

    Nutrients, Vol. 14, Núm. 13

2021

  1. Association of biochemical parameters of bone metabolism with progression and/or development of new aortic calcifications

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 13, Núm. 1, pp. 10-16

  2. Contribution of phosphorus and PTH to the development of cardiac hypertrophy and fibrosis in an experimental model of chronic renal failure

    Nefrologia, Vol. 41, Núm. 6, pp. 640-651

  3. Effects of calcitriol and paricalcitol on renal fibrosis in CKD

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 36, Núm. 5, pp. 793-803

  4. Fibrosis in chronic kidney disease: Pathogenesis and consequences

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-19